NPCE – neuropace, inc. (US:NASDAQ)
Stock Stats
News
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024 [Yahoo! Finance]
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
Revamp Medical Announces Appointment of Mike Favet as CEO [Yahoo! Finance]
NeuroPace, Inc. (NASDAQ: NPCE) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $16.00.
Form 4 NeuroPace Inc For: Apr 24 Filed by: ORBIMED ADVISORS LLC
Form 4 NeuroPace Inc For: Apr 19 Filed by: ORBIMED ADVISORS LLC
Form ARS NeuroPace Inc For: Dec 31
Form DEFA14A NeuroPace Inc
Form DEF 14A NeuroPace Inc For: Jun 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.